John Snow Labs Awarded Phase I SBIR Contract for the Development of Medical Large Language Models for Infectious and Immune-Mediated Diseases
September 17, 2024 09:00 ET
|
John Snow Labs
John Snow Labs has been awarded an SBIR Phase I contract from NIAID for the development of medical LLMs for infectious and immune-mediated diseases.
[Latest] Global Wearable Robots Market Size/Share Worth USD 13.6 Billion by 2033 at a 32.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
September 16, 2024 17:30 ET
|
Custom Market Insights
Austin, TX, USA, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Wearable Robots Market Size, Trends and Insights By Type (Powered Exoskeletons,...
Medigene to Host Virtual R&D Event on Medigene’s Optimal 3S TCRs for TCR-Guided Precision Immunotherapies
September 16, 2024 08:30 ET
|
Medigene AG
Planegg/Martinsried, September 16, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor...
L'AIAC et ISDE publient le plus récent rapport sur l'état de l'industrie aérospatiale canadienne
July 11, 2024 14:00 ET
|
L'Association des industries aérospatiales du Canada
OTTAWA, 11 juill. 2024 (GLOBE NEWSWIRE) -- Des données récemment publiées révèlent que l'industrie aérospatiale canadienne montre des signes de reprise économique et continue d'être un moteur...
AIAC & ISED Release Latest State Of Canada’s Aerospace Industry Report
July 11, 2024 14:00 ET
|
Aerospace Industries Association of Canada (AIAC)
Aerospace Industries Association of Canada, in partnership with ISED, release the latest State of Canada’s Aerospace Industry Report.
Tevogen Bio’s R&D Leadership Discusses The Promise of Its Genetically Unmodified, Off-The-Shelf T Cell Technology For The Treatment of Infectious Diseases, Cancers, and Neurological Disorders With Nasdaq's Kristina Ayanian
July 10, 2024 08:05 ET
|
Tevogen Bio Inc
Dr. Flomenberg and Dr. Grosso are leading experts in T cell biology and its clinical applicationsTevogen’s ExacTcell™ platform is designed to address current cost, and patient accessibility...
Resonac Announces New US-JOINT Consortium; Ten Partners to Collaborate on Next-Generation Semiconductor Packaging in Silicon Valley
July 08, 2024 08:07 ET
|
Resonac Holdings Corporation
Resonac Corporation today unveiled a new consortium of ten partners, called “US-JOINT,” for its semiconductor back-end process R&D in Silicon Valley.
CBIH Charts Path to Future Leadership in Cannabis Medicine
July 08, 2024 08:00 ET
|
CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.
A letter from our desk HOUSTON, July 08, 2024 (GLOBE NEWSWIRE) -- Since the start of the year, Cannabis Bioscience International Holdings (OTCMKTS: CBIH) has embarked on a transformative journey...
CBIH advances Cancer Care with Novel Cannabis Patents for Breast and Pancreatic Cancers
July 01, 2024 08:00 ET
|
CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.
Cannabis Bioscience International Holdings (OTCMKTS: CBIH) is excited to announce the submission of our inaugural pair of patents, focusing on novel treatm
Nxera Pharma Receives US$10 Million from AbbVie as Collaboration Targeting Neurological Diseases Achieves First R&D Milestone
June 26, 2024 19:05 ET
|
Nxera Pharma
Tokyo, Japan and Cambridge, UK, 27 June 2024 - Nxera Pharma Co. Ltd (“Nxera”; TSE 4565), announces that it has reached an important R&D milestone under its multi-target discovery collaboration...